Board of Directors
Ali Behbahani, M.D.
General Partner, New Enterprise Associates
Dr. Kapil Dhingra
Former Head, Roche Oncology Development
Dr. Wendy Dixon
Former Global Marketing Head, Bristol Myers Squibb
David M. Epstein, Ph.D.
Founder, President & Chief Executive Officer
Samarth (Sam) Kulkarni, Ph.D.
CEO, CRISPR Therapeutics AG
Alexander Mayweg, Ph.D.
Managing Partner, Versant Ventures
Garry E. Menzel, Ph.D.
President and CEO of TCR2 Therapeutics
Managing Partner, RA Capital Management
Mark A. Velleca, M.D., Ph.D.